Research Outputs
Permanent URI for this communityhttps://hdl.handle.net/20.500.14288/2
Browse
1 results
Search Results
Publication Metadata only Discovery of novel CYP17 inhibitors for the treatment of prostate cancer with structure-based drug design(Bentham Science Publ Ltd, 2009) N/A; N/A; N/A; Department of Chemical and Biological Engineering; Department of Industrial Engineering; Armutlu, Pelin; Özdemir, Muhittin Emre; Özdaş, Şule Beyhan; Kavaklı, İbrahim Halil; Türkay, Metin; Master Student; Master Student; Researcher; Faculty Member; Faculty Member; Department of Chemical and Biological Engineering; Department of Industrial Engineering; Graduate School of Sciences and Engineering; Graduate School of Sciences and Engineering; Graduate School of Sciences and Engineering; College of Engineering; College of Engineering; N/A; N/A; N/A; 40319; 24956It has been shown that prostate cancer is associated with elevated androgen biosynthesis; therefore, inhibiting the activity of Cytochrome P450 17 (CYP17) may prevent progression of prostate cancer. In this study we identified, using in silico and experimental methods, two novel steroidal and non-steroidal lead compounds that inhibit the activity CYP17.